Indofarma Tbk. vs Prima Cakrawala Abadi Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Prima Cakrawala Abadi Tbk. trades at Rp43 (market cap 51.33B, 1.56M 24h volume). The key difference: Indofarma Tbk. is far larger — about 7.6× Prima Cakrawala Abadi Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | PCAR | |
|---|---|---|
Market Cap | 390.51B | 51.33B |
Volume | — | 1.56M |
Lot | — | 15.58K |
Turnover | — | 66.98M |
Average Price | — | 43 |
Value | — | 66.98M |
Indicative Equilibrium Price | — | 43 |
Indicative Equilibrium Volume | — | 1.03K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →The Company was established with the name of PT Prima Abadi is a limited company that was established based on the deed of establishment Limited Company PT Prima Cakrawala Abadi No. 111 issued on January 29 2014. The Articles of Association of the company has been experiencing some changes, the updated was the Decision of the Shareholders No. 20 issued on September 19, 2017. The company started commercial business activities in the year 2014.
Read more on PCAR →